Current and historical daily PE Ratio for PEN (
Penumbra Inc
) from 2015 to Apr 18 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Penumbra stock (PEN) PE ratio as of Apr 18 2024 is 87.38.
More Details
Penumbra Inc (PEN) PE Ratio (TTM) Chart
Penumbra Inc (PEN) PE Ratio (TTM) Historical Data
View and export this data going back to 2015. Start your Free Trial
Total 1210
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Penumbra PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-04-18 | 87.4 | 2024-02-13 | 114.6 |
| 2024-04-17 | 90.3 | 2024-02-12 | 116.9 |
| 2024-04-16 | 90.9 | 2024-02-09 | 118.2 |
| 2024-04-15 | 91.0 | 2024-02-08 | 117.9 |
| 2024-04-12 | 94.1 | 2024-02-07 | 114.7 |
| 2024-04-11 | 96.3 | 2024-02-06 | 112.0 |
| 2024-04-10 | 95.7 | 2024-02-05 | 110.4 |
| 2024-04-09 | 96.5 | 2024-02-02 | 109.1 |
| 2024-04-08 | 95.3 | 2024-02-01 | 110.1 |
| 2024-04-05 | 97.0 | 2024-01-31 | 109.2 |
| 2024-04-04 | 93.3 | 2024-01-30 | 108.3 |
| 2024-04-03 | 93.1 | 2024-01-29 | 110.7 |
| 2024-04-02 | 91.6 | 2024-01-26 | 109.3 |
| 2024-04-01 | 94.1 | 2024-01-25 | 108.5 |
| 2024-03-28 | 96.6 | 2024-01-24 | 106.8 |
| 2024-03-27 | 98.0 | 2024-01-23 | 109.5 |
| 2024-03-26 | 95.6 | 2024-01-22 | 109.4 |
| 2024-03-25 | 95.3 | 2024-01-19 | 108.4 |
| 2024-03-22 | 97.3 | 2024-01-18 | 110.7 |
| 2024-03-21 | 98.5 | 2024-01-17 | 111.3 |
| 2024-03-20 | 102.3 | 2024-01-16 | 113.9 |
| 2024-03-19 | 103.5 | 2024-01-12 | 111.9 |
| 2024-03-18 | 101.5 | 2024-01-11 | 111.8 |
| 2024-03-15 | 96.2 | 2024-01-10 | 108.2 |
| 2024-03-14 | 99.4 | 2024-01-09 | 106.1 |
| 2024-03-13 | 101.0 | 2024-01-08 | 107.1 |
| 2024-03-12 | 103.6 | 2024-01-05 | 100.3 |
| 2024-03-11 | 104.6 | 2024-01-04 | 100.1 |
| 2024-03-08 | 105.9 | 2024-01-03 | 100.3 |
| 2024-03-07 | 109.5 | 2024-01-02 | 106.0 |
| 2024-03-06 | 108.0 | 2023-12-29 | 108.9 |
| 2024-03-05 | 111.0 | 2023-12-28 | 110.6 |
| 2024-03-04 | 108.0 | 2023-12-27 | 252.6 |
| 2024-03-01 | 102.5 | 2023-12-26 | 252.6 |
| 2024-02-29 | 101.7 | 2023-12-22 | 251.1 |
| 2024-02-28 | 99.9 | 2023-12-21 | 251.1 |
| 2024-02-27 | 100.6 | 2023-12-20 | 239.8 |
| 2024-02-26 | 100.1 | 2023-12-19 | 244.7 |
| 2024-02-23 | 103.2 | 2023-12-18 | 240.2 |
| 2024-02-22 | 113.7 | 2023-12-15 | 238.3 |
| 2024-02-21 | 111.8 | 2023-12-14 | 245.5 |
| 2024-02-20 | 116.3 | 2023-12-13 | 233.3 |
| 2024-02-16 | 117.1 | 2023-12-12 | 222.7 |
| 2024-02-15 | 118.3 | 2023-12-11 | 217.6 |
| 2024-02-14 | 116.2 | 2023-12-08 | 217.5 |
Penumbra Inc (PEN) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Penumbra Inc
NAICS : 339999
SIC : 3841
ISIN : US70975L1070
Description
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers